Label-free detection of hepatocellular carcinoma markers based on photoluminescence of antibody-conjugated ZnO arrays

Journal of Biomedical Nanotechnology

Volumn 9, Issue 12, 2013, Pages 2024-2033

  He, Mian ^a   Huang, Zhongbing ^a   Yan, Xiang ^a   Liao, Xiaoming ^a   Yin, Guangfu ^a   Duan, Aoshu ^a   Gu, Jianwen ^b  

^a SICHUAN UNIVERSITY   (China)

^b Military General Hospital of Chengdu PLA   (China)

Author keywords

Hepatocellular Carcinoma (HCC); Hierarchical ZnO arrays; Label Free detection; Photoluminescence; Tumor markers

Indexed keywords

ALPHAFETOPROTEIN (AFP); CARBODIIMIDE CHEMISTRY; CARCINOEMBRYONIC ANTIGEN; HEPATOCELLULAR CARCINOMA; HIERARCHICAL ZNO; LABEL-FREE DETECTION; PHOTOLUMINESCENCE INTENSITIES; TUMOR MARKERS;

ANTIBODIES; ANTIGENS; DIAGNOSIS; PHOTOLUMINESCENCE; SCREENING; ZINC OXIDE;

CHEMICAL DETECTION;

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYANAMIDE; ZINC OXIDE;

ADSORPTION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; ELECTRON; ENERGY TRANSFER; HUMAN; INFRARED SPECTROSCOPY; LIVER CELL CARCINOMA; PHOTOLUMINESCENCE; POWDER DIFFRACTION; PRECIPITATION; PROTEIN SECONDARY STRUCTURE; SCANNING ELECTRON MICROSCOPY;

ANTIBODIES, NEOPLASM; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, HEPATOCELLULAR; EARLY DETECTION OF CANCER; HUMANS; IMMUNOASSAY; LIVER NEOPLASMS; LUMINESCENT MEASUREMENTS; PROTEIN ARRAY ANALYSIS; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL; ZINC OXIDE;

EID: 84888795291     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1747     Document Type: Article

References (54)

1. http://www.who.int/en/.
2. F. X. Bosch, J. Ribes, M. Diaz, and R. Cleries, Worldwide incidence and trends. Gastroenterology 127, S5 (2004).
3. I. Ikai, S. Arii, T. Ichida, K. Okita, M. Omata, M. Kojiro, K. Takayasu, Y. Nakanuma, M. Makuuchi, Y. Matsuyama, and Y. Yamaoka, Report of the 16th follow-up survey of primary liver cancer. Hepatol. Res. 32, 163 (2005).
4. S. Coulon, F. Heindryckx, A. Geerts, C. V. Steenkiste, I. Colle, and H. V. Vlierberghe, Angiogenesis in chronic liver disease and its complications. 31, 146 (2011).
5. A. Wiesner, Detection of tumor markers with protein chip technology. Curr. Pharm. Biotechnol. 5, 45 (2004).
6. A. A. Amayo and J. G. Kuria, Clinical application of tumour markers: A review. East Afr. Med. J. 86, S76 (2009).
7. J. Snarska, S. D. Szajda, Z. Puchalski, M. Szmitkowski, E. Chabielska, F. Kaminski, P. Zwierz, and K. Zwierz, Usefulness of examination of some tumor markers in diagnostics of liver cancer. Hepatogastroenterology 53, 271 (2006).
8. T. W. Warnes and A. Smith, Tumour markers in diagnosis and management. Baillieres Clin. Gastroenterol. 1, 63 (1987).
9. M. J. Duffy, Carcinoembryonic antigen as a marker for colorectal cancer: Is it clinically useful? Clin. Chem. 47, 624 (2001).
10. S. Fujiyama, M. Tanaka, S. Maeda, H. Ashihara, R. Hirata, and K. Tomita, Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma. Oncology 62(suppl 1), 57 (2002).
11. J. R. Gillespie and V. N. Uversky, Structure and function of alphafetoprotein: A biophysical overview. BBA-Protein Struct. Mol. Enzymol. 1480, 41 (2000).
12. D. G. Tu, S. T. Wang, T. T. Chang, N. T. Chiu, and W. J. Yao, The value of serum tissue polypeptide specific antigen in the diagnosis of hepatocellular carcinoma. Cancer 85, 1039 (1999).
13. L. Chen, D. W. Y. Ho, N. P. Y. Lee, S. Sun, B. Lam, K. F. Wong, X. Yi, G. K. Lau, E. W. Y. Ng, T. C. W. Poon, P. B. S. Lai, Z. W. Cai, J. R. Peng, X. S. Leng, R. T. P. Poon, and J. M. Luk, Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker. Ann. Surg. Oncol. 17, 2518 (2010).
14. M. E. El-Houseini, M. S. Mohammed, W. M. Elshemey, T. D. Hussein, O. S. Desouky, and A. A. Elsayed, Enhanced detection of hepatocellular carcinoma. Cancer Control 12, 248 (2005).
15. G. H. Zhang, R. Pu, and Q. S. Xin, The application of alpha-fetoprotein, carbohydrate antigen-125, carbohydrate antigen-199 and carcinoembryonic antigen in hepatopathy. Chin. J. Clin. Rational Drug Use 3, 56 (2010).
16. T. Chen, T. Ali, A. Mangnishahan, K. Asi, Y. Yang, and Y. X. Bao, The influence of the combined detecion of tumor makers and image examination on diagnosis of liver cancer. Lab. Med. Clinic 8, 1956 (2011).
17. M. J. A. Engelen, H. W. A. de Bruijn, H. Hollema, K. A. ten Koor, P. H. B. Willemse, J. G. Aalders, and A. G. J. van der Zee, Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors. Gynecol. Oncol. 78, 16 (2000).
18. R. C. Bast, Jr, T. L. Klug, E. Schaetzl, P. Lavin, J. M. Niloff, T. F. Greber, V. R. Zurawski, Jr, and R. C. Knapp, Monitoring human ovarian carcinoma with a combination of CA 125, CA 19- 9, and carcinoembryonic antigen. Am. J. Obstet. Gynecol. 149, 553 (1984).
19. B. Chang, P. Gray, M. Piltch, M. S. Bulgin, S. Sorensen-Melson, M. W. Miller, P. Davies, D. R. Brown, D. R. Coughlin, and R. Rubenstein, Surround optical fiber immunoassay (SOFIA): An ultra-sensitive assay for prion protein detection. J. Virol. Methods 159, 15 (2009).
20. R. Rubenstein, B. Chang, P. Gray, M. Piltch, M. S. Bulgin, S. Sorensen-Melson, and M. W. Miller, Prion disease detection, PMCA kinetics, and IgG in urine from sheep naturally/experimentally infected with scrapie and deer with preclinical/clinical chronic wasting disease. J. Virol. 85, 9031 (2011).
21. R. Gabl, H. D. Feucht, H. Zeininger, G. Eckstein, M. Schreiter, R. Primig, D. Pitzer, and W. Wersing, First results on label-free detection of DNA and protein molecules using a novel integrated sensor technology based on gravimetric detection principles. Biosens. Bioelectron. 19, 615 (2004).
22. J. Wang, Nanomaterial-based electrochemical biosensors. Analyst 130, 421 (2005).
23. X. L. Chen, Y. F. Huang, and W. H. Tan, Using aptamer-nanoparticle conjugates for cancer cells detection. J. Biomed. Nanotechnol. 4, 400 (2008).
24. S. P. Singh, Multifunctional magnetic quantum dots for cancer theranostics. J. Biomed. Nanotechnol. 7, 95 (2011).
25. Z. Li, R. Yang, M. Yu, F. Bai, C. Li, and Z. L. Wang, Cellular level biocompatibility and biosafety of ZnO nanowires. J. Phys. Chem. 112, 20114 (2008).
26. K. Schilling, B. Bradford, D. Castelli, E. Dufour, J. F. Nash, W. Pape, S. Schulte, I. Tooley, J. van den Bosch, and F. Schellauf, Human safety review of "nano" titanium dioxide and zinc oxide. Photoch. Photobio. Sci. 9, 495 (2010).
27. J. C. Soria, J. Cortes, C. Massard, J. P. Armand, D. De Andreis, S. Ropert, E. Lopez, A. Catteau, J. James, J. F. Marier, M. Beliveau, R. E. Martell, and J. Baselga, Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors. Ann. Oncol. 23, 463 (2012).
28. T. Y. Liu, H. C. Liao, C. C. Lin, S. H. Hu, and S. Y. Chen, Biofunctional ZnO nanorod arrays grown on flexible substrates. Langmuir 22, 5804 (2006).
29. A. Dorfman, N. Kumar, and J. Hahm, Nanoscale ZnO-enhanced fluorescence detection of protein interactions. Adv. Mater. 18, 2685 (2006).
30. A. Dorfman, N. Kumar, and J. I. Hahm, Highly sensitive biomolecular fluorescence detection using nanoscale ZnO platforms. Langmuir 22, 4890 (2006).
31. N. Kumar, A. Dorfman, and J. Hahm, Ultrasensitive DNA sequence detection using nanoscale ZnO sensor arrays. Nanotechnology 17, 2875 (2006).
32. A. Dorfman, O. Parajuli, N. Kumar, and J. I. Hahm, Novel telomeric repeat elongation assay performed on zinc oxide nanorod array supports. J. Nanosci. Nanotechno. 8, 410 (2008).
33. W. Hu, Y. Liu, H. Yang, X. Zhou, and C. M. Li, ZnO nanorodsenhanced fluorescence for sensitive microarray detection of cancers in serum without additional reporter-amplification. Biosens. Bioelectron. 26, 3683 (2011).
34. W. Hu, Y. Liu, Z. Zhu, H. Yang, and C. M. Li, Randomly oriented ZnO nanorods as advanced substrate for high-performance protein microarrays. ACS Appl. Mater. Inter. 2, 1569 (2010).
35. J. A. Hagen, S. N. Kim, B. Bayraktaroglu, K. Leedy, J. L. Chavez, N. Kelley-Loughnane, R. R. Naik, and M. O. Stone, Biofunctionalized zinc oxide field effect transistors for selective sensing of riboflavin with current modulation. Sensors 11, 6645 (2011).
36. F. N. Ishikawa, H.-K. Chang, M. Curreli, H.-I. Liao, C. A. Olson, P.-C. Chen, R. Zhang, R. W. Roberts, R. Sun, R. J. Cote, M. E. Thompson, and C. Zhou, Label-free, electrical detection of the SARS virus N-Protein with nanowire biosensors utilizing antibody mimics as capture probes. ACS Nano 3, 1219 (2009).
37. H. W. Ra, J. T. Kim, R. Khan, D. Sharma, Y. G. Yook, Y. B. Hahn, J. H. Park, D. G. Kim, and Y. H. Im, Robust and multifunctional nanosheath for chemical and biological nanodevices. Nano Lett. 12, 1891 (2012).
38. G. Shan, S. Wang, X. Fei, Y. Liu, and G. Yang, Heterostructured ZnO/Au nanoparticles-based resonant raman scattering for protein detection. J. Phys. Chem. B 113, 1468 (2009).
39. M. Yang, G. F. Yin, Z. B. Huang, X. M. Liao, Y. Q. Kang, and Y. D. Yao, Well-aligned ZnO rod arrays grown on glass substrate from aqueous solution. Appl. Surf. Sci. 254, 2917 (2008).
40. M. Yang, G. F. Yin, Z. B. Huang, Y. Q. Kang, X. M. Liao, and H. Wang, Preparation and optical properties of biomimic hierarchical ZnO column arrays. Cryst. Growth Des. 9, 707 (2009).
41. M. Yang, Z. Huang, G. Yin, X. Liao, Y. Yao, Y. Kang, and J. Gu, Effect of thermal treatment on the structure and optical properties of biomimic hierarchical ZnO column arrays. J. Alloy Compd. 495, 275 (2010).
42. B. Batteiger, W. J. Newhall, and R. B. Jones, The use of Tween 20 as a blocking agent in the immunological detection of proteins transferred to nitrocellulose membranes. J. Immunol. Methods 55, 297 (1982).
43. S. Zampieri, A. Ghirardello, A. Doria, M. Tonello, R. Bendo, K. Rossini, and P. F. Gambari, The use of Tween 20 in immunoblotting assays for the detection of autoantibodies in connective tissue diseases. J. Immunol. Methods 239, 1 (2000).
44. X. Yan, Z. Huang, M. He, X. Liao, C. Zhang, G. Yin, and J. Gu, Detection of HCG-antigen based on enhanced photoluminescence of hierarchical ZnO arrays. Colloids Surf. B 89, 86 (2012).
45. K. Postava, H. Sueki, M. Aoyama, T. Yamaguchi, C. Ino, Y. Igasaki, and M. Horie, Spectroscopic ellipsometry of epitaxial ZnO layer on sapphire substrate. J. Appl. Phys. 87, 7820 (2000).
46. T. C. Damen, S. P. S. Porto, and B. Tell, Raman effect in zinc oxide. Phys. Rev. 142, 570 (1966).
47. C. A. Arguello, D. L. Rousseau, and S. P. S. Porto, First-order raman effect in Wurtzite-type crystals. Phys. Rev. 181, 1351 (1969).
48. J. M. Calleja and M. Cardona, Resonant Raman scattering in ZnO. Phys. Rev. B 16, 3753 (1977).
49. B. Cheng, W. Sun, J. Jiao, B. Tian, Y. Xiao, and S. Lei, Disorder-induced Raman scattering effects in one-dimensional ZnO nanostructures by incorporation and anisotropic distribution of Dy and Li codopants. J. Raman Spectrosc. 41, 1221 (2010).
50. B. Zhang, X. Zhang, H. H. Yan, S. J. Xu, D. H. Tang, and W. L. Fu, A novel multi-array immunoassay device for tumor markers based on insert-plug model of piezoelectric immunosensor. Biosens. Bioelectron. 23, 19 (2007).
51. J. Li, Z. B. Huang, D. W. Wu, G. F. Yin, X. M. Liao, J. W. Gu, and D. Han, Preparation and protein detection of Zn ferrite film with magnetic and photoluminescence properties. J. Phys. Chem. C 114, 1586 (2010).
52. S. R. Beyer, S. Ullrich, S. Kudera, A. T. Gardiner, R. J. Cogdell, and J. Kohler, Hybrid nanostructures for enhanced light-harvesting: Plasmon induced increase in fluorescence from individual photosynthetic pigment-protein complexes. Nano Lett. 11, 4897 (2011).
53. D. K. Gale, T. Gutu, J. Jiao, C.-H. Chang, and G. L. Rorrer, Photoluminescence detection of biomolecules by antibody-functionalized diatom biosilica. Adv. Funct. Mater. 19, 926 (2009).
54. A. Fernández-San Millán, A. Mingo-Castel, M. Miller, and H. Daniell, A chloroplast transgenic approach to hyper-express and purify human serum albumin, a protein highly susceptible to proteolytic degradation. Plant Biotechnol. J. 1, 71 (2003).